438 related articles for article (PubMed ID: 8381085)
1. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
3. Isolation of an endogenous Na-pump specific inhibitor from normal pig urine: characterization and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Naruse M; Sakakibara M; Inagami T
Biochim Biophys Acta; 1993 May; 1157(1):15-22. PubMed ID: 8388731
[TBL] [Abstract][Full Text] [Related]
4. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Konishi F; Inagami T
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
Tamura M; Harris TM; Higashimori K; Sweetman BJ; Blair IA; Inagami T
Biochemistry; 1987 May; 26(10):2797-806. PubMed ID: 3038164
[TBL] [Abstract][Full Text] [Related]
6. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet.
Tamura M; Harris TM; Phillips D; Blair IA; Wang YF; Hellerqvist CG; Lam SK; Inagami T
J Biol Chem; 1994 Apr; 269(16):11972-9. PubMed ID: 8163500
[TBL] [Abstract][Full Text] [Related]
7. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
8. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
9. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
Gonick HC; Weiler EW; Prins BA; Purdy RE
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
[TBL] [Abstract][Full Text] [Related]
11. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
[TBL] [Abstract][Full Text] [Related]
12. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
[TBL] [Abstract][Full Text] [Related]
13. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
Kramer HJ; Baecker A; Weiler E; Liddiard C
Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
[TBL] [Abstract][Full Text] [Related]
14. Identification of Na+,K+-ATPase inhibitors of volume-expanded hog plasma.
Inagami T; Tamura M
Hypertension; 1987 Nov; 10(5 Pt 2):I108-12. PubMed ID: 2824359
[TBL] [Abstract][Full Text] [Related]
15. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
Tal DM; Yanuck MD; van Hall G; Karlish SJ
Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
Yasuhara T; Mori M; Wakamatsu K; Kubo K
Biochem Biophys Res Commun; 1991 Jul; 178(1):95-103. PubMed ID: 1648917
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
18. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
[TBL] [Abstract][Full Text] [Related]
19. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
20. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
